Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VTV THERAPEUTICS INC.

(VTVT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Retreat Friday

09/24/2021 | 01:15pm EDT


© MT Newswires 2021
All news about VTV THERAPEUTICS INC.
10/20VTV THERAPEUTICS : Names Deepa Prasad CEO, President
MT
10/20VTV THERAPEUTICS : Announces Deepa Prasad as New President and CEO - Form 8-K
PU
10/20VTV THERAPEUTICS INC. : Change in Directors or Principal Officers, Financial Statements an..
AQ
10/20VTV THERAPEUTICS : Announces Deepa Prasad as New President and CEO
PR
10/20VTv Therapeutics Inc. Announces Executive Changes
CI
10/20VTv Therapeutics Inc. Announces Executive Changes
CI
10/12VTV THERAPEUTICS' : Diabetes Drug Trial Achieves Primary Endpoint
MT
10/12vTv Therapeutics Announces Positive Results from Mechanistic Study Indicating No Increa..
GL
10/12VTV THERAPEUTICS : Announces Positive Results from Mechanistic Study Indicating No Increas..
GL
10/12VTv Therapeutics Announces Positive Results from Mechanistic Study Indicating No Increa..
CI
More news
Financials (USD)
Sales 2021 3,00 M - -
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 84,3 M 84,3 M -
Capi. / Sales 2021 28,1x
Capi. / Sales 2022 84,3x
Nbr of Employees 25
Free-Float 28,2%
Chart VTV THERAPEUTICS INC.
Duration : Period :
vTv Therapeutics Inc. Technical Analysis Chart | VTVT | US9183851057 | MarketScreener
Technical analysis trends VTV THERAPEUTICS INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,40 $
Average target price 6,75 $
Spread / Average Target 382%
Managers and Directors
Stephen L. Holcombe President & Chief Executive Officer
Rudy C. Howard EVP, Chief Financial & Accounting Officer
Robin E. Abrams Executive Chairman
Aaron H. Burstein Senior Vice President-Clinical Development
Carmen Valcarce Chief Scientific Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
VTV THERAPEUTICS INC.-24.73%84
GILEAD SCIENCES, INC.15.41%84 306
BIONTECH SE241.44%67 225
WUXI APPTEC CO., LTD.24.51%64 578
REGENERON PHARMACEUTICALS18.47%59 507
VERTEX PHARMACEUTICALS-22.35%47 610